Skip to main content
OpenTrials
Completed

NCT Number: NCT04433754

The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Although COVID-19 disease due to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract, heart and coagulation system, symptoms of gastrointestinal system involvement such as abdominal pain, nausea, vomiting and diarrhea are also common.

In this study, it was aimed retrospective analysis of clinical and laboratory data of patients who developed pancreatic injury in the course of COVID 19 disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pancreatitis Digestive System Diseases Pancreatic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Usak University Training and Research Hospital

Uşak, 64200, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with amylase and lipase levels measured during covid-19 disease with or without pneumonia

Exclusion criteria

  • Patients with pregnancy
  • Patients whose amylase and lipase levels were not measured during covid 19 disease
  • Patients with known solid organ malignacy
  • Patients with known hematologic malignacy

Treatment and study plan

biochemical analysis

Other

cRP, d-dimer levels and lymphocyte counts will be compared

Primary outcomes

  1. to compare presence of fever in patients with and without pancreatic injury

    Time frame: 3 month

    To evaluate the frequency of presence of fever in patients with and without pancreatic injury

  2. to compare presence of dyspnea in patients with and without pancreatic injury

    Time frame: 3 month

    To evaluate the frequency of presence of dyspnea in patients with and without pancreatic injury

  3. To compare cRP levels in patients with and without pancreatic injury

    Time frame: 3 month

    CRP levels will be compared in patients with and without pancreatic injury

  4. To compare d-dimer levels in patients with and without pancreatic injury

    Time frame: 3 month

    D-Dimer levels will be compared in patients with and without pancreatic injury

Sponsors and collaborators

Lead sponsor

Uşak University

Other

Registry information

Official study title

Pancreatic Injury in Patients With COVID-19 Disease

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jun 16, 2020
Registry last updated
Jun 16, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.